SEARCH

SEARCH BY CITATION

References

  • Akasaka, T., Lossos, I.S. & Levy, R. (2003) BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood, 102, 14431448.
  • Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., Powell, J.I., Yang, L., Marti, G.E., Moore, T., Hudson, Jr, J., Lu, L., Lewis, D.B., Tibshirani, R., Sherlock, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Armitage, J.O., Warnke, R., Levy, R., Wilson, W., Grever, M.R., Byrd, J.C., Botstein, D., Brown, P.O. & Staudt, L.M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503511.
  • Armitage, J.O., Dick, F.R. & Corder, M.P. (1981) Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant. Cancer Treatment Reports, 65, 413418.
  • Bastion, Y., Sebban, C., Berger, F., Felman, P., Salles, G., Dumontet, C., Bryon, P.A. & Coiffier, B. (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. Journal of Clinical Oncology, 15, 15871594.
  • Boonstra, R., Bosga-Bouwer, A., Mastik, M., Haralambieva, E., Conradie, J., Van Den Berg, E., Van Den Berg, A. & Poppema, S. (2003) Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma. Human Pathology, 34, 915923.
  • Capello, D., Vitolo, U., Pasqualucci, L., Quattrone, S., Migliaretti, G., Fassone, L., Ariatti, C., Vivenza, D., Gloghini, A., Pastore, C., Lanza, C., Nomdedeu, J., Botto, B., Freilone, R., Buonaiuto, D., Zagonel, V., Gallo, E., Palestro, G., Saglio, G., Dalla-Favera, R., Carbone, A. & Gaidano, G. (2000) Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood, 95, 651659.
  • Chen, C.I., Crump, M., Tsang, R., Stewart, A.K. & Keating, A. (2001) Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. British Journal of Haematology, 113, 202208.
  • Cullen, M.H., Lister, T.A., Brearley, R.I., Shand, W.S. & Stansfeld, A.G. (1979) Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer, 44, 645651.
  • Dahia, P.L., Aguiar, R.C., Honegger, J., Fahlbush, R., Jordan, S., Lowe, D.G., Lu, X., Clayton, R.N., Besser, G.M. & Grossman, A.B. (1998) Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Oncogene, 16, 6976.
  • Davies, A.J., Lee, A.M., Taylor, C., Clear, A.J., Goff, L.K., Iqbal, S., Cuthbert-Heavens, D., Calaminici, M., Norton, A.J., Lister, T.A. & Fitzgibbon, J. (2005) A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia, 19, 14591465.
  • Elenitoba-Johnson, K.S., Gascoyne, R.D., Lim, M.S., Chhanabai, M., Jaffe, E.S. & Raffeld, M. (1998) Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood, 91, 46774685.
  • Elenitoba-Johnson, K.S., Jenson, S.D., Abbott, R.T., Palais, R.A., Bohling, S.D., Lin, Z., Tripp, S., Shami, P.J., Wang, L.Y., Coupland, R.W., Buckstein, R., Perez-Ordonez, B., Perkins, S.L., Dube, I.D. & Lim, M.S. (2003) Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proceedings of the National Academy of Sciences of the United States of America, 100, 72597264.
  • Garvin, A.J., Simon, R.M., Osborne, C.K., Merrill, J., Young, R.C. & Berard, C.W. (1983) An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute. Cancer, 52, 393398.
  • Gatenby, R.A. & Gillies, R.J. (2004) Why do cancers have high aerobic glycolysis? Nature Reviews. Cancer, 4, 891899.
  • Geschwind, J.F., Georgiades, C.S., Ko, Y.H. & Pedersen, P.L. (2004) Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma. Expert Review of Anticancer Therapy, 4, 449457.
  • Glas, A.M., Kersten, M.J., Delahaye, L.J., Witteveen, A.T., Kibbelaar, R.E., Velds, A., Wessels, L.F., Joosten, P., Kerkhoven, R.M., Bernards, R., Van Krieken, J.H., Kluin, P.M., Van't Veer, L.J. & De Jong, D. (2005) Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood, 105, 301307.
  • Goff, L.K., Neat, M.J., Crawley, C.R., Jones, L., Jones, E., Lister, T.A. & Gupta, R.K. (2000) The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. British Journal of Haematology, 111, 618625.
  • Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Delabie, J., Ott, G., Muller-Hermelink, H.K., Campo, E., Braziel, R.M., Jaffe, E.S., Pan, Z., Farinha, P., Smith, L.M., Falini, B., Banham, A.H., Rosenwald, A., Staudt, L.M., Connors, J.M., Armitage, J.O. & Chan, W.C. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275282.
  • Horning, S.J. & Rosenberg, S.A. (1984) The natural history of initially untreated low-grade non-Hodgkin's lymphomas. The New England Journal of Medicine, 311, 14711475.
  • Hough, R.E., Goepel, J.R., Alcock, H.E., Hancock, B.W., Lorigan, P.C. & Hammond, D.W. (2001) Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B-cell lymphoma. British Journal of Cancer, 84, 499503.
  • Hubbard, S.M., Chabner, B.A., DeVita, Jr, V.T., Simon, R., Berard, C.W., Jones, R.B., Garvin, A.J., Canellos, G.P., Osborne, C.K. & Young, R.C. (1982) Histologic progression in non-Hodgkin's lymphoma. Blood, 59, 258264.
  • Iqbal, S., Jenner, M.J., Summers, K.E., Davies, A.J., Matthews, J., Norton, A.J., Calaminici, M., Rohatiner, A.Z., Fitzgibbon, J., Lister, T.A. & Goff, L.K. (2004a) Reliable detection of clonal IgH/Bcl2 MBR rearrangement in follicular lymphoma: methodology and clinical significance. British Journal of Haematology, 124, 325328.
  • Iqbal, J., Sanger, W.G., Horsman, D.E., Rosenwald, A., Pickering, D.L., Dave, B., Dave, S., Xiao, L., Cao, K., Zhu, Q., Sherman, S., Hans, C.P., Weisenburger, D.D., Greiner, T.C., Gascoyne, R.D., Ott, G., Muller-Hermelink, H.K., Delabie, J., Braziel, R.M., Jaffe, E.S., Campo, E., Lynch, J.C., Connors, J.M., Vose, J.M., Armitage, J.O., Grogan, T.M., Staudt, L.M. & Chan, W.C. (2004b) BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. The American Journal of Pathology, 165, 159166.
  • Kern, S.E., Pietenpol, J.A., Thiagalingam, S., Seymour, A., Kinzler, K.W. & Vogelstein, B. (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science, 256, 827830.
  • Labuhn, M., Jones, G., Speel, E.J., Maier, D., Zweifel, C., Gratzl, O., Van Meir, E.G., Hegi, M.E. & Merlo, A. (2001) Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Oncogene, 20, 11031109.
  • Leonard, B.M., Hetu, F., Busque, L., Gyger, M., Belanger, R., Perreault, C. & Roy, D.C. (1998) Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: less than one log difference between bone marrow and peripheral blood sources. Blood, 91, 331339.
  • Lo Coco, F., Gaidano, G., Louie, D.C., Offit, K., Chaganti, R.S. & Dalla-Favera, R. (1993) p53 mutations are associated with histologic transformation of follicular lymphoma. Blood, 82, 22892295.
  • Lossos, I.S. & Levy, R. (2000) Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood, 96, 635639.
  • Lossos, I.S., Alizadeh, A.A., Diehn, M., Warnke, R., Thorstenson, Y., Oefner, P.J., Brown, P.O., Botstein, D. & Levy, R. (2002) Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proceedings of the National Academy of Sciences of the United States of America, 99, 88868891.
  • Martinez-Climent, J.A., Alizadeh, A.A., Segraves, R., Blesa, D., Rubio-Moscardo, F., Albertson, D.G., Garcia-Conde, J., Dyer, M.J., Levy, R., Pinkel, D. & Lossos, I.S. (2003) Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood, 101, 31093117.
  • Marutani, M., Tonoki, H., Tada, M., Takahashi, M., Kashiwazaki, H., Hida, Y., Hamada, J., Asaka, M. & Moriuchi, T. (1999) Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. Cancer Research, 59, 47654769.
  • Matolcsy, A., Warnke, R.A. & Knowles, D.M. (1997) Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma. Annals of Oncology, 8 (Suppl. 2), 119122.
  • Nagy, M., Balazs, M., Adam, Z., Petko, Z., Timar, B., Szereday, Z., Laszlo, T., Warnke, R.A. & Matolcsy, A. (2000) Genetic instability is associated with histological transformation of follicle center lymphoma. Leukemia, 14, 21422148.
  • Pastorino, J.G., Shulga, N. & Hoek, J.B. (2002) Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. The Journal of Biological Chemistry, 277, 76107618.
  • Price, C.G., Meerabux, J., Murtagh, S., Cotter, F.E., Rohatiner, A.Z., Young, B.D. & Lister, T.A. (1991) The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. Journal of Clinical Oncology, 9, 15271532.
  • Rosenwald, A., Wright, G., Chan, W.C., Connors, J.M., Campo, E., Fisher, R.I., Gascoyne, R.D., Muller-Hermelink, H.K., Smeland, E.B., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Yang, L., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Powell, J., Duffey, P.L., Longo, D.L., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Montserrat, E., Lopez-Guillermo, A., Grogan, T.M., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. & Staudt, L.M. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. The New England Journal of Medicine, 346, 19371947.
  • Rosenwald, A., Wright, G., Wiestner, A., Chan, W.C., Connors, J.M., Campo, E., Gascoyne, R.D., Grogan, T.M., Muller-Hermelink, H.K., Smeland, E.B., Chiorazzi, M., Giltnane, J.M., Hurt, E.M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W.H., Jaffe, E.S., Simon, R., Klausner, R.D., Montserrat, E., Bosch, F., Greiner, T.C., Weisenburger, D.D., Sanger, W.G., Dave, B.J., Lynch, J.C., Vose, J., Armitage, J.O., Fisher, R.I., Miller, T.P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L.M. (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell, 3, 185197.
  • Sander, C.A., Yano, T., Clark, H.M., Harris, C., Longo, D.L., Jaffe, E.S. & Raffeld, M. (1993) p53 mutation is associated with progression in follicular lymphomas. Blood, 82, 19942004.
  • Schoder, H., Noy, A., Gonen, M., Weng, L., Green, D., Erdi, Y.E., Larson, S.M. & Yeung, H.W. (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 23, 46434651.
  • Shaffer, A.L., Rosenwald, A., Hurt, E.M., Giltnane, J.M., Lam, L.T., Pickeral, O.K. & Staudt, L.M. (2001) Signatures of the immune response. Immunity, 15, 375385.
  • Shi, X.B., Nesslinger, N.J., Deitch, A.D., Gumerlock, P.H. & De Vere White, R.W. (2002) Complex functions of mutant p53 alleles from human prostate cancer. The Prostate, 51, 5972.
  • Szereday, Z., Csernus, B., Nagy, M., Laszlo, T., Warnke, R.A. & Matolcsy, A. (2000) Somatic mutation of the 5′ noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma. The American Journal of Pathology, 156, 10171024.
  • De Vos, S., Hofmann, W.K., Grogan, T.M., Krug, U., Schrage, M., Miller, T.P., Braun, J.G., Wachsman, W., Koeffler, H.P. & Said, J.W. (2003) Gene expression profile of serial samples of transformed B-cell lymphomas. Laboratory Investigation, 83, 271285.
  • Williams, C.D., Harrison, C.N., Lister, T.A., Norton, A.J., Blystad, A.K., Coiffier, B., Taghipour, G., Schmitz, N. & Goldstone, A.H. (2001) High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry. Journal of Clinical Oncology, 19, 727735.
  • Wright, G.W. & Simon, R.M. (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics, 19, 24482455.
  • Wright, G., Tan, B., Rosenwald, A., Hurt, E.H., Wiestner, A. & Staudt, L.M. (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 100, 99919996.
  • Yano, T., Jaffe, E.S., Longo, D.L. & Raffeld, M. (1992) MYC rearrangements in histologically progressed follicular lymphomas. Blood, 80, 758767.